| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $104K | — | +943.1% |
| R&D Expense | $27K | — | +151.9% |
| SG&A Expense | $2.4M | — | -26.5% |
| Operating Income | -$3.3M | — | +19.7% |
| Pre-tax Income | -$3.0M | — | +16.5% |
| Income Tax | $47K | — | — |
| Net Income | -$3.1M | — | +15.2% |
| EPS (Basic) | -$0.51 | — | -466.7% |
| EPS (Diluted) | -$0.51 | — | -466.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.8M | +946.3% | +662.4% |
| Accounts Receivable | $130K | -47.9% | +219.0% |
| Current Assets | $3.6M | +119.9% | +91.2% |
| Total Assets | $16.3M | +6.6% | -9.1% |
| Current Liabilities | $8.3M | -23.1% | -41.0% |
| Total Liabilities | $9.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.7M | — | -41.7% |
| Investing Cash Flow | -$140K | — | -27.0% |
| Financing Cash Flow | $5.5M | — | +94.5% |
| -38.3% |
| Stockholders' Equity | $7.3M | +110.4% | +119.8% |